Pierce Protease Inhibitor Tablets, EDTA-free, 20 Tablets
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0480950
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $350.65
About this award
Life Technologies Corporation has been awarded a contract by the University of Virginia to supply laboratory reagents and supplies. The award, identified as A207_PO-0480950, was executed on September 16, 2026, with a cumulative contract value of $350. The procurement is located in Virginia and involves the delivery of specialized laboratory materials to support the University's research and operational requirements.
The primary deliverable under this contract is one unit of Pierce Protease Inhibitor Tablets, ethylenediaminetetraacetic acid (EDTA)-free, 20 tablets, priced at $350.65 per unit. The product is designated for delivery to Anna Olson at the University of Virginia. This procurement represents a routine purchase of laboratory-grade biochemical reagents typically utilized in protein analysis and sample preparation protocols within research or diagnostic settings.
Line items
| Item | Total |
|---|---|
| Pierce Protease Inhibitor Tablets, EDTA-free, 20 Tablets | $350.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0480950?
Contract A207_PO-0480950 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on September 16, 2026.
How much is contract A207_PO-0480950 worth?
Its cumulative value is $350.65.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award